Newomics: Funding, Investors & Team (Sep 2026)
Newomics is an early stage biotechnology company that commercializes innovative and integrative platforms and solutions for personalized healthcare. Its proprietary technology is based on silicon-microfluidic-chip for liquid chromatography-mass spectrometry (LC-MS) and offers unprecedented robustness, sensitivity, specificity, and throughput for analyzing molecules from minute amounts of biospecimens such as blood and urine.
Newomics has raised $7.9M across 1 funding round on record, the most recent an undisclosed round of $7.9M announced in Dec 2020.
That round is in line with the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Newomics Company Profile and Key Stats
Latest funding round on record: Dec 2020.
Newomics Funding Rounds
Newomics Founders and Leadership Team
Contact details for the Newomics team: 1 of 1 has an email address on file.
Start 14-day free trial →Newomics Funding Compared to Other Biotechnology Startups
Newomics' latest round of $7.9M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Newomics in Biotechnology and Berkeley
Companies Similar to Newomics
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…
Shennon Biotechnologies conducts a thorough examination and control of an enormous quantity of cells,…
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
Newomics Funding FAQs
What does Newomics do?
Newomics is an early stage biotechnology company that commercializes innovative and integrative platforms and solutions for personalized healthcare. Its proprietary technology is based on silicon-microfluidic-chip for liquid chromatography-mass spectrometry (LC-MS) and offers unprecedented robustness, sensitivity, specificity, and throughput for analyzing molecules from minute amounts of biospecimens such as blood and urine.
How much funding has Newomics raised?
Newomics has raised $7.9M across 1 round on record. The most recent is an undisclosed round of $7.9M announced in Dec 2020.
When did Newomics last raise funding?
Newomics' most recent funding round on record is an undisclosed round of $7.9M, announced in Dec 2020.
Who is the CEO of Newomics?
Daojing Wang is listed as CEO at Newomics.
Where is Newomics headquartered?
Newomics is based in Berkeley, California, United States.
How many employees does Newomics have?
Newomics is in the 11-50 employee band.
How does Newomics' funding compare to other Biotechnology startups?
Newomics' latest round of $7.9M is in line with the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Newomics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Newomics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.